Navigation Links
PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022
Date:9/18/2013

London (PRWEB) September 18, 2013

Summary

GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the presence of the BCR-ABL fusion protein. The stage of CML is classified as chronic, accelerated or blast phase, ranging from least to most severe. Multiple BCR-ABL tyrosine kinase inhibitors (TKIs) are approved, and are the standard of care for CML. TKIs have transformed most cases of the disease into a manageable, chronic condition. As a result, patients’ survival rates and the prevalence of CML are increasing, placing a growing burden on global healthcare systems

This decline will be driven by the launch of generic imatinib in 2015 and generic dasatinib in 2020; the increased uptake of higher-priced therapies like Bosulif and Iclusig will not be able to fully counteract the generic erosion of these two market-leading drugs. Aside from Synribo, which was launched in 2012, the US market consists exclusively of BCR-ABL TKIs; the TKIs will remain the dominant therapeutic class over the forecast period due to their convenience and excellent efficacy and safety profiles.

Scope

  • Overview of the CML including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
  • Detailed information on the key drugs in the US including product description, safety and efficacy profiles as well as a SWOT analysis.
  • Sales forecast for the top drugs in the US from 2012-2022.
  • Analysis of the impact of key events as well the drivers and restraints affecting the US CML market.

Reasons to buy

  • Understand and capitalize by identifying products that
    '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022
2. Predicting who will have chronic pain
3. Treatment Rates of Prevalent Chronic Conditions Are Low in Brazil, According to Kantar Health Research
4. Chronic Kidney Disease Market: 81M CKD Cases by 2022 Says a New Research Report at ReportsnReports.com
5. Chronic Fatigue Treatment
6. How “End Tiredness Program” Helps People Get Rid Of Tiredness – Vinamy
7. Chronic Pain Resulting from Chronic Prostatitis Can Be Terminated by A New Herbal Medicine Without Side Effects, Highlights Wuhan Dr.Lee's TCM Clinic
8. New research gives answers on the relationship between chronic illness and food insecurity
9. The Chopra Center Launches Mind-Body Healing Program for Chronic Pain
10. Concerns Rise About New Phentermine Drug According to Houston Chronicle Report
11. Does chronic pain affect a spouses sleep?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... of research suggesting a safe and effective role ... cancer, with fewer detrimental side effects and improved ... study will be published in final format today ... Endocrinology . , Breast cancer is the most ... States. Approximately 70% of breast cancers are diagnosed ...
(Date:7/23/2014)... of Biomedical Imaging and Bioengineering will host its second ... 2014 on the NIH campus. There will be ten ... breadth of NIBIB-funded research. , WHO: ... Rhodopsins as Optical Voltage Sensor, Quyen Nguyen, Univ. ... Nerve Imaging during Surgery, ...
(Date:7/23/2014)... 2014 The American Telemedicine Association ... twentieth annual meeting and tradeshow focused exclusively on ... attract over 5,000 attendees and more than 250 ... 3-5, 2015, in Los Angeles. , ATA’s annual ... professionals from researchers, clinicians, hospital and university administrators, ...
(Date:7/23/2014)... New York (PRWEB) July 23, 2014 ... continue to move forward in a federal multidistrict litigation ... Bernstein Liebhard LLP reports. According to an Order dated ... a hospital’s bid for payment of a $1,000 fee ... hip implant. , Among other things, the Order ...
(Date:7/23/2014)... Fragile X syndrome ( FXS ) is a ... other behaviors on the autistic spectrum, as well as ... of mental impairment and the most common cause of ... California, Riverside have published a study that ... FXS. Appearing online today (July 23) in the ...
Breaking Medicine News(10 mins):Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5Health News:ATA Seeks Speakers to Present at the World’s Largest Telemedicine, mHealth and Telehealth Conference 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 4Health News:Study links enzyme to autistic behaviors 2Health News:Study links enzyme to autistic behaviors 3
... 6, 2009) The American Association of Pharmaceutical Scientists ... Ph.D., to the position of Research Fellow at the ... she will begin work this week to develop effective ... appointment comes at the end of a collaborative effort ...
... 12th annual Boston Stroke Luncheon "Making the Stroke Connection" will ... Boston from 7:30 a.m. to 12 p.m. Activities include a ... End Stroke Ambassador Training, and an awards celebration lunch from ... Janet Wu. , Milton Resident Margaret Kelly-Hayes, EdD, ...
... big chunk of change" to make Jen Ross smile. This ... raise more than $1,000 for Custom Hearts , ... heart defects or heart disease."Now that we have a big chunk ... things that we,ve wanted to do for a year and a ...
... Misperceptions About Donation Are CommonRICHMOND, Va., April 14 ... organ and tissue donors is rising, the registry still ... a report card issued by Donate Life America this ... Americans, 72 percent of people want their decision to ...
... Nu Skin Enterprises, Inc. (NYSE: NUS ) ... to the market opening on April 30, 2009. Truman ... call with the investment community later that same day beginning ... expect to hear management discuss past results as well as ...
... Association Becomes Only Major Parkinson,s Organization to Launch ... Parkinson,s DiseaseSTATEN ISLAND, N.Y., April 14 The ... Center has launched a re-designed Web site, ... onset Parkinson,s disease (PD), their family members, friends, ...
Cached Medicine News:Health News:AAPS and FDA announce appointment of research fellow 2Health News:Milton resident receives the Helen B. Spaulding Community Conscience Award 2Health News:TAN's Efforts Produce 'Chunk of Change' for Children With Heart Defects 2Health News:While the Majority of Americans Express Interest in Organ and Tissue Donation, Too Few Take Steps to Register as Donors 2Health News:While the Majority of Americans Express Interest in Organ and Tissue Donation, Too Few Take Steps to Register as Donors 3Health News:New Young Onset Parkinson's Disease Web Site Goes Live 2Health News:New Young Onset Parkinson's Disease Web Site Goes Live 3
(Date:7/23/2014)...  Cardica, Inc. (Nasdaq: CRDC ) today announced ... quarter and year ended June 30, 2014, on Thursday, August ... a conference call at 4:30 p.m. Eastern Time to discuss ... business. Conference Call Details To access the live ... Time via phone, please dial 866-953-6859 from the ...
(Date:7/23/2014)... -- Global healthcare company GSK reports Q2 ... increased price competition and supply disruptions to its Consumer ... points out that the company is very much in transition, ... confident about long-term prospects as well as the investments ... Simon Dingemans adds that the company is ...
(Date:7/23/2014)... ENGLEWOOD, Colo. , July 23 2014 ... opening of its new headquarters, manufacturing and research facility: ... Englewood, CO 80112 Direct: (720) 437-6500 ... advanced, labor efficient, pharmaceutical drug manufacturing facility will be ... to produce the first batches of Ampion TM ...
Breaking Medicine Technology:Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014 2Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado 2
... Pa., Feb. 16, 2011 AirPal, a medical device ... of allowance from the U.S. Patent Office for its ... for situations such as difficult airway management, laryngoscopies, diagnostic ... founded in 1982, now holds more than a dozen ...
... YORK, Feb. 16, 2011 Get content from ... The European Parliament is expected ... prevent falsified medicines from entering the legal distribution ... packages have reached patients in the last years. ...
Cached Medicine Technology:AirPal Receives Patent for Inflatable Patient Positioning Systems 2
Mounted on a sturdy, molded headband,the Classic has a fully adjustable crown,strap and cushioning that adds to,your comfort....
The Convertible lets you attach the,High Lite optic directly to your loupes....
... is a product of AlloSource, one ... human tissue processing, and Interpore Cross, ... InterGro combines AlloGro DBM with ... deliver a unique bone graft that ...
Immunoassay for the detection of Group A streptococcal antigen directly from throat swab specimens. ,Rapid, accurate diagnosis assures prompt treatment....
Medicine Products: